Andrew C Harris
Overview
Explore the profile of Andrew C Harris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lakkaraja M, Mauguen A, Boulad F, Cancio M, Curran K, Harris A, et al.
Cytotherapy
. 2024 Feb;
26(4):351-359.
PMID: 38349310
Background Aims: Traditional weight-based dosing of rabbit anti-thymocyte globulin (rATG) used in allogeneic hematopoietic cell transplantation (HCT) to prevent graft-versus-host disease (GVHD) and graft rejection leads to variable exposures. High...
12.
Kunvarjee B, Contreras Yametti G, Blouin A, Linder G, Borge P, Maryamchik E, et al.
Br J Haematol
. 2024 Jan;
204(4):1540-1544.
PMID: 38212144
No abstract available.
13.
Meyers G, Hamadani M, Martens M, Ali H, Chevallier P, Choe H, et al.
Bone Marrow Transplant
. 2023 Sep;
58(12):1416-1418.
PMID: 37749187
No abstract available.
14.
Kunvarjee B, Bidgoli A, Madan R, Vidal E, McAvoy D, Hosszu K, et al.
J Allergy Clin Immunol
. 2023 Jun;
152(3):815-817.
PMID: 37367708
No abstract available.
15.
Takahashi T, Al-Kofahi M, Jaber M, Bratrude B, Betz K, Suessmuth Y, et al.
Blood
. 2023 Jun;
142(8):700-710.
PMID: 37319437
In the ABA2 study, the T-cell costimulation blockade agent, abatacept, was safe and effective in preventing acute graft-versus-host disease (aGVHD) after unrelated-donor hematopoietic cell transplant (HCT), leading to US Food...
16.
Cuvelier G, Ng B, Abdossamadi S, Nemecek E, Melton A, Kitko C, et al.
Blood Adv
. 2022 Oct;
7(14):3612-3623.
PMID: 36219586
The National Institutes of Health Consensus criteria for chronic graft-versus-host disease (cGVHD) diagnosis can be challenging to apply in children, making pediatric cGVHD diagnosis difficult. We aimed to identify diagnostic...
17.
Carpenter P, Kang H, Yoo K, Zecca M, Cho B, Lucchini G, et al.
Transplant Cell Ther
. 2022 Aug;
28(11):771.e1-771.e10.
PMID: 36044977
Chronic graft-versus-host disease (cGVHD) is a potentially life-threatening complication of allogeneic hematopoietic stem cell transplantation. Clinical data surrounding cGVHD therapies in younger children are limited and critically needed. Primary endpoints...
18.
Harris A, Muelken P, Alcheva A, Stepanov I, Lesage M
Front Neurosci
. 2022 Jun;
16:868088.
PMID: 35712461
Conventional tobacco cigarettes appear to have greater abuse liability than non-combusted products such as electronic cigarettes (ECs) and nicotine replacement therapy (NRT). This may be due to the higher levels...
19.
OBrien M, Ji L, Shah N, Rheingold S, Bhojwani D, Yuan C, et al.
J Clin Oncol
. 2022 Jan;
40(9):956-967.
PMID: 35007127
Purpose: Children's Oncology Group trial AALL1621 was conducted to prospectively determine the safety and efficacy of inotuzumab ozogamicin (InO) in pediatric and adolescent patients with relapsed or refractory (R/R) B-cell...
20.
Meyers G, Hamadani M, Martens M, Ali H, Choe H, Dawson P, et al.
Bone Marrow Transplant
. 2021 Nov;
57(2):302-303.
PMID: 34815518
No abstract available.